A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainNew insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathyTreatment-related progressive multifocal leukoencephalopathy: current understanding and future stepsNovel approaches and challenges to treatment of central nervous system viral infectionsProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.Small-molecule inhibitors of JC polyomavirus infectionIncidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseasesInflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.CNS Demyelination with TNF-α BlockersInflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.Beyond the joints: neurological involvement in rheumatoid arthritis.Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.Biologics in oral medicine: principles of use and practical considerations.Assessing the safety of biologic agents in patients with rheumatoid arthritis.Challenges and approaches for the development of safer immunomodulatory biologics.Adverse reactions to biologic agents and their medical management.A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy.Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2.JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database.JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.Human T-cell lymphotropic virus (HTLV)-associated encephalopathy: an under-recognised cause of acute encephalitis? Case series and literature review.Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab.
P2860
Q21285083-61EBA26F-794F-44DC-A3FB-FB2F32150CDCQ24619923-BD197811-D226-4014-BEE7-D3240F623665Q26822247-6AE6061D-9C7E-4566-8022-FBC284459F0CQ26823444-37B6D55B-4317-4743-91C3-D3785E1C03F4Q26862449-C014C742-DEBD-4230-8B46-8A3175DC66D8Q30235523-5A1A202A-6854-4A54-853E-7288CFC87159Q30245002-0BA51C11-648A-440B-9067-0BB84A214221Q30815289-5B043E4B-2C1A-4587-89E3-2E792455A77AQ35529977-AF817D40-EEFF-47CC-978E-EE98E43E078AQ35846542-EFCB1D6A-EECE-4128-99A4-4F2B97137572Q37198798-5C437F18-DA3B-42E2-B58C-2366A066C08DQ37361949-DBDA2C2F-C464-46E9-A3BF-A8BDC57F29DEQ37719132-0AEF2B14-E0DC-4D54-8378-0F4D155D304BQ37911726-28D2A59F-90B0-4183-9B0A-30C0F354D15FQ37935613-F9D33219-8985-44D1-BBEE-4482D4B04097Q37980042-EA52F929-DB65-4A95-A9BE-330F2244D395Q37993932-852843ED-3077-44CA-A833-45DB87957DC1Q38020463-635A065B-7EB0-4390-BD17-CCEC425E4BCCQ38093772-2A897F12-9847-4794-95AE-0CAF59E86251Q38238948-01BD2FA3-4432-4716-88FA-DEA993CE596DQ38268951-F405EEA3-EC97-4E1C-8080-86BF1024A60AQ39476021-1DF50A46-5DB1-4CE3-976D-6ECB5FD636AEQ40502531-7D29DE97-6145-4C7A-B1C9-3C705843608BQ41178481-501C5F01-1E16-4AAE-9D26-3D9DA812F1FAQ41921811-817D42D1-F2BD-4D22-84DF-A7D99F3AC873Q50104047-84B63D2F-55DE-429F-96D0-1BF59D58D5FCQ54374397-CAA42815-4BA8-4D8C-9D2E-5335370638FC
P2860
A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A case of progressive multifoc ...... tient treated with infliximab.
@ast
A case of progressive multifoc ...... tient treated with infliximab.
@en
A case of progressive multifoc ...... tient treated with infliximab.
@nl
type
label
A case of progressive multifoc ...... tient treated with infliximab.
@ast
A case of progressive multifoc ...... tient treated with infliximab.
@en
A case of progressive multifoc ...... tient treated with infliximab.
@nl
prefLabel
A case of progressive multifoc ...... tient treated with infliximab.
@ast
A case of progressive multifoc ...... tient treated with infliximab.
@en
A case of progressive multifoc ...... tient treated with infliximab.
@nl
P2093
P2860
P356
P1476
A case of progressive multifoc ...... tient treated with infliximab.
@en
P2093
Deepak Kumar
Robert G Berger
Thomas W Bouldin
P2860
P304
P356
10.1002/ART.27687
P577
2010-11-01T00:00:00Z